- Home
- CHR vs IMNN Comparison
CHR vs IMNN Comparison
Compare CHR & IMNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CHR
- IMNN
- Stock Information
- Founded
- CHR 2016
- IMNN 1982
- Country
- CHR China
- IMNN United States
- Employees
- CHR N/A
- IMNN N/A
- Industry
- CHR EDP Services
- IMNN Biotechnology: Pharmaceutical Preparations
- Sector
- CHR Technology
- IMNN Health Care
- Exchange
- CHR Nasdaq
- IMNN Nasdaq
- Market Cap
- CHR 12.9M
- IMNN 12.1M
- IPO Year
- CHR N/A
- IMNN 1985
- Fundamental
- Price
- CHR $1.18
- IMNN $6.53
- Analyst Decision
- CHR
- IMNN Buy
- Analyst Count
- CHR 0
- IMNN 2
- Target Price
- CHR N/A
- IMNN $182.61
- AVG Volume (30 Days)
- CHR 87.5K
- IMNN 246.6K
- Earning Date
- CHR 07-30-2025
- IMNN 08-05-2025
- Dividend Yield
- CHR N/A
- IMNN N/A
- EPS Growth
- CHR N/A
- IMNN N/A
- EPS
- CHR 1.76
- IMNN N/A
- Revenue
- CHR $147,134,000.00
- IMNN N/A
- Revenue This Year
- CHR N/A
- IMNN N/A
- Revenue Next Year
- CHR N/A
- IMNN N/A
- P/E Ratio
- CHR $0.67
- IMNN N/A
- Revenue Growth
- CHR N/A
- IMNN N/A
- 52 Week Low
- CHR $1.00
- IMNN $4.83
- 52 Week High
- CHR $3.45
- IMNN $41.22
- Technical
- Relative Strength Index (RSI)
- CHR 37.15
- IMNN 40.89
- Support Level
- CHR $1.08
- IMNN $6.17
- Resistance Level
- CHR $2.03
- IMNN $7.21
- Average True Range (ATR)
- CHR 0.09
- IMNN 0.51
- MACD
- CHR -0.03
- IMNN 0.14
- Stochastic Oscillator
- CHR 13.16
- IMNN 20.45
About CHR Cheer Holding Inc.
Cheer Holding Inc is a provider of next generation mobile internet infrastructure and platform services in China. It is engaged in building a digital ecosystem that integrates platforms, applications, technology, and industry into a cohesive system, thereby creating a new, open business environment that leverages AI technology. Its portfolio includes various products and services, such as Polaris Intelligent Cloud, CHEERS Telepathy, CHEERS Open Platform, CHEERS Video, CHEERS e-Mall, CheerReal, CheerCar, CheerChat, CHEERS Fresh Group-Buying E-commerce Platform, Digital Innovation Research Institute, CHEERS Livestreaming, variety show series, IP short video matrix, and more.
About IMNN Imunon Inc.
Imunon Inc is a clinical-stage biotechnology company focused on advancing a portfolio of treatments that harness the body's natural mechanisms to generate safe, effective, and durable responses across various human diseases, constituting a differentiating approach from conventional therapies. It is developing its non-viral DNA technology across its modalities. Its clinical program, IMNN-001, is a DNA-based immunotherapy for the localized treatment of ovarian cancer that has completed Phase II clinical studies. Additionally, the Company has entered a first-in-human study of its COVID-19 booster vaccine (IMNN-101).